Home  >  Product Launches
Eppen_Research3_6neo_Aug26
you can get e-magazine links on WhatsApp. Click here
Product Launches
  Glenmark Pharmaceuticals launches sugammadex injection,   July 29, 2026
  Bristol Myers Squibb launches Relopduo for metastatic melanoma,   July 27, 2026
  RPG Life Sciences partners with Archerchem Healthcare to launch Naprosyn ES,   July 13, 2026
  Novo Nordisk launches once-weekly basal insulin Awiqli in India,   July 10, 2026
  Cetaphil launches new AM/PM Antioxidant Serum Duo in India,   July 09, 2026
  Omnigel launches Omnigel Maxstrong; marks its entry into long-lasting relief,   July 07, 2026
  Akums Drugs & Pharma launches pregabalin, methylcobalamin and duloxetine DR capsules,   July 01, 2026
  Shaily Engineering Plastics announces regulatory approval and launch of customer combination product incorporating its ShailyPen Neo Device Technology,   May 21, 2026
  Dr Reddy’s Labs launches oral semaglutide biosimilar ‘Obeda’ tablets in India,   May 20, 2026
  Roche Pharma India launches subcutaneous immunotherapy for lung cancer, Tecentriq SC,   May 14, 2026
  AstraZeneca launches K+ Connect to advance hyperkalaemia management in heart failure and CKD across India,   May 13, 2026
  Lilly launches Lormalzi, first and only once-monthly amyloid plaque-targeting therapy to treat early symptomatic Alzheimer’s disease in India,   May 13, 2026
  Akums launches advanced antibiotic aztreonam-avibactam to tackle drug-resistant infections,   April 28, 2026
  MSN Laboratories introduces Semabest, the first integrated made-in-India semaglutide,   April 15, 2026
  USV launches “usema” to address India’s metabolic health burden,   March 26, 2026
  Sun Pharma introduces semaglutide injection under the brand names, Noveltreat and Sematrinity in India,   March 21, 2026
  Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes,   March 21, 2026
  Eris brings breakthrough diabetes therapy accessible with weekly shot of semaglutide starting at Rs. 220 per shot,   March 20, 2026
  Akums launches first-of-its-kind Lasmiditan dispersible tablets for rapid migraine care,   March 18, 2026
  Zydus introduces biosimilar Aflibercept 2 mg Anyra for advancing ophthalmic care,   February 19, 2026

  • Results Found: 625
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 32
 Back
 
NPME-2026
cphi_korea2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram